PT2373988E - Métodos para medir concentrações de biomoléculas - Google Patents
Métodos para medir concentrações de biomoléculas Download PDFInfo
- Publication number
- PT2373988E PT2373988E PT98312093T PT09831209T PT2373988E PT 2373988 E PT2373988 E PT 2373988E PT 98312093 T PT98312093 T PT 98312093T PT 09831209 T PT09831209 T PT 09831209T PT 2373988 E PT2373988 E PT 2373988E
- Authority
- PT
- Portugal
- Prior art keywords
- biomolecules
- methods
- measuring concentrations
- concentrations
- measuring
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2458/00—Labels used in chemical analysis of biological material
- G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2496/00—Reference solutions for assays of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12032608P | 2008-12-05 | 2008-12-05 | |
| US12032908P | 2008-12-05 | 2008-12-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2373988E true PT2373988E (pt) | 2015-06-03 |
Family
ID=42233633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98312093T PT2373988E (pt) | 2008-12-05 | 2009-12-04 | Métodos para medir concentrações de biomoléculas |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10481167B2 (pt) |
| EP (2) | EP2891882B1 (pt) |
| JP (1) | JP6166016B2 (pt) |
| CA (1) | CA2745839C (pt) |
| DK (1) | DK2373988T3 (pt) |
| ES (1) | ES2536436T3 (pt) |
| PT (1) | PT2373988E (pt) |
| WO (1) | WO2010065878A1 (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009062152A1 (en) * | 2007-11-09 | 2009-05-14 | Washington University In St. Louis | Methods for measuring the metabolism of cns derived biomolecules in vivo |
| EP2891882B1 (en) | 2008-12-05 | 2018-08-15 | C2N Diagnostics | Methods for measuring concentrations of biomolecules |
| EP2575596B1 (en) * | 2010-05-24 | 2016-04-20 | The Washington University | Methods of determining amyloid beta turnover in blood |
| WO2012045324A1 (en) * | 2010-10-07 | 2012-04-12 | Mediagnost Gesellschaft Fur Forschung Und Herstellung Von Diagnostika Gmbh | Method for detecting a parkinson's disease and test system |
| JP6371219B2 (ja) * | 2011-09-19 | 2018-08-08 | シー２エヌ ダイアグノスティクス | 神経性および神経変性の疾患、障害、および関連過程の診断および治療のための方法 |
| AU2012346476B2 (en) * | 2011-10-17 | 2015-10-01 | Randall J. Bateman | Metabolism of SOD1 in CSF |
| WO2013082307A1 (en) * | 2011-12-02 | 2013-06-06 | C2N Diagnostics | Methods for measuring concentrations of biomolecules |
| US9678086B2 (en) | 2012-09-10 | 2017-06-13 | The Johns Hopkins University | Diagnostic assay for Alzheimer's disease |
| AU2013348049A1 (en) * | 2012-11-20 | 2015-05-28 | Washington University | Methods of diagnosing amyloid pathologies using analysis of amyloid-beta enrichment kinetics |
| BR112017006419A2 (pt) | 2014-09-30 | 2017-12-19 | Univ Washington | medições cinéticas de tau |
| US11360098B2 (en) * | 2015-09-28 | 2022-06-14 | Quest Diagnostics Investments Llc | Amyloid beta detection by mass spectrometry |
| CA3064843A1 (en) | 2016-06-06 | 2017-12-14 | Uvic Industry Partnerships Inc. | Assay for quantitation of proteins and peptides using stable isotope standards |
| CN110100181A (zh) * | 2016-12-19 | 2019-08-06 | Uab研究基金会 | 用于血红蛋白β和镰状血红蛋白β的质谱标准及其用途 |
| EP3579859A4 (en) | 2017-02-10 | 2020-12-16 | C2N Diagnostics, LLC | METHOD OF MEASUREMENT OF BIOMOLECULE CONCENTRATIONS IN BIOFLUIDS |
| US10322760B2 (en) * | 2017-03-30 | 2019-06-18 | Caterpillar Inc. | Undercarriage clamping master track link |
| US12066444B2 (en) | 2017-05-01 | 2024-08-20 | Washington University | Blood-based methods for determining Aβ amyloidosis |
| US11085935B2 (en) | 2018-05-03 | 2021-08-10 | Washington University | Methods of treating based on site-specific tau phosphorylation |
| WO2022176612A1 (ja) * | 2021-02-22 | 2022-08-25 | 株式会社 島津製作所 | 質量分析装置で用いられるキャリブラント及びその作製方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2225313A1 (en) | 1995-06-21 | 1997-01-09 | Martek Biosciences Corporation | Combinatorial libraries of labeled biochemical compounds and methods for producing same |
| US6653076B1 (en) | 1998-08-31 | 2003-11-25 | The Regents Of The University Of Washington | Stable isotope metabolic labeling for analysis of biopolymers |
| AU3888100A (en) | 1999-03-15 | 2000-10-04 | Proteotech, Inc. | Therapeutic and diagnostic applications of p400: a newly discovered beta-amyloidbinding protein present in human biological fluids |
| DE60324393D1 (de) | 2002-02-12 | 2008-12-11 | Univ California | Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte |
| US7501286B2 (en) | 2002-08-14 | 2009-03-10 | President And Fellows Of Harvard College | Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry |
| US20040096907A1 (en) * | 2002-11-06 | 2004-05-20 | Bernd Bohrmann | Quantification of beta amyloid |
| EP1420254A3 (en) | 2002-11-06 | 2004-05-26 | F. Hoffmann-La Roche Ag | Amyloid quantification |
| EP2208992A1 (en) * | 2003-11-21 | 2010-07-21 | Eisai R&D Management Co., Ltd. | Quantitation method using isotope labeled internal standard substance, analysis system for executing the quantitation method, and program for the analysis |
| ATE554391T1 (de) * | 2003-12-19 | 2012-05-15 | Max Planck Gesellschaft | Verfahren zur analyse von metaboliten |
| CA2955027A1 (en) | 2004-04-15 | 2005-11-10 | University Of Florida Research Foundation, Inc. | Neural proteins as biomarkers for nervous system injury and other neural disorders |
| US20080206737A1 (en) * | 2004-05-19 | 2008-08-28 | Hunter Christie L | Expression quantification using mass spectrometry |
| WO2006017812A1 (en) | 2004-08-07 | 2006-02-16 | Kinemed, Inc. | Method for measuring dynamics of self-assembling systems of biological molecules in vivo and uses for discovering or evaluating therapeutic agents |
| US20060110784A1 (en) | 2004-09-22 | 2006-05-25 | The Scripps Research Institute | Site-specific labeling of proteins for NMR studies |
| WO2006107814A2 (en) | 2005-04-06 | 2006-10-12 | Washington University In St. Louis | Methods for measuring the metabolism of neurally derived biomolecules in vivo |
| US20070134802A1 (en) | 2005-06-30 | 2007-06-14 | Heinz Doebeli | Ionization modifier for mass spectrometry |
| US8288110B2 (en) | 2006-12-04 | 2012-10-16 | Perkinelmer Health Sciences, Inc. | Biomarkers for detecting cancer |
| EP2082237A2 (en) | 2006-12-06 | 2009-07-29 | Universität Zürich | Means and methods for isolating and determining novel targets for the treatment of neurodegenerative, neurological or neuropsychiatric disorders and compositions comprising the same |
| US20080220449A1 (en) * | 2007-02-08 | 2008-09-11 | Oligomerix, Inc. | Biomarkers and assays for Alzheimer's disease |
| US8323654B2 (en) | 2007-05-14 | 2012-12-04 | Medtronic, Inc. | Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules |
| WO2008146100A1 (en) | 2007-06-01 | 2008-12-04 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for absolute quantification of polypeptides |
| WO2009062152A1 (en) | 2007-11-09 | 2009-05-14 | Washington University In St. Louis | Methods for measuring the metabolism of cns derived biomolecules in vivo |
| US20110312059A1 (en) | 2008-08-20 | 2011-12-22 | Oligomerix Inc. | Tau protease compositions and methods |
| US9464122B2 (en) | 2008-08-20 | 2016-10-11 | Oligomerix, Inc. | Methods and compositions comprising tau oligomers |
| EP2891882B1 (en) | 2008-12-05 | 2018-08-15 | C2N Diagnostics | Methods for measuring concentrations of biomolecules |
| JP6371219B2 (ja) | 2011-09-19 | 2018-08-08 | シー２エヌ ダイアグノスティクス | 神経性および神経変性の疾患、障害、および関連過程の診断および治療のための方法 |
-
2009
- 2009-12-04 EP EP15155419.3A patent/EP2891882B1/en active Active
- 2009-12-04 US US13/132,307 patent/US10481167B2/en active Active
- 2009-12-04 EP EP09831209.3A patent/EP2373988B1/en active Active
- 2009-12-04 CA CA2745839A patent/CA2745839C/en active Active
- 2009-12-04 DK DK09831209.3T patent/DK2373988T3/en active
- 2009-12-04 PT PT98312093T patent/PT2373988E/pt unknown
- 2009-12-04 ES ES09831209.3T patent/ES2536436T3/es active Active
- 2009-12-04 JP JP2011539743A patent/JP6166016B2/ja active Active
- 2009-12-04 WO PCT/US2009/066810 patent/WO2010065878A1/en active Application Filing
-
2013
- 2013-08-15 US US13/967,816 patent/US20140065636A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010065878A1 (en) | 2010-06-10 |
| US20120015371A1 (en) | 2012-01-19 |
| EP2891882A1 (en) | 2015-07-08 |
| US20140065636A1 (en) | 2014-03-06 |
| EP2373988A1 (en) | 2011-10-12 |
| DK2373988T3 (en) | 2015-05-11 |
| JP2012511154A (ja) | 2012-05-17 |
| EP2891882B1 (en) | 2018-08-15 |
| CA2745839A1 (en) | 2010-06-10 |
| EP2373988A4 (en) | 2012-06-13 |
| JP6166016B2 (ja) | 2017-07-19 |
| CA2745839C (en) | 2017-09-19 |
| ES2536436T3 (es) | 2015-05-25 |
| EP2373988B1 (en) | 2015-02-18 |
| US10481167B2 (en) | 2019-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2373988A4 (en) | METHODS OF MEASURING CONCENTRATIONS OF BIOMOLECULES | |
| EP2238699A4 (en) | METHOD FOR INTERFERENCE MEASUREMENT | |
| EP2435128A4 (en) | METHOD AND DEVICE FOR ANALYTIC MEASUREMENT | |
| GB2462829B (en) | Measurement method | |
| GB2458368B (en) | Measurement of ion mobility spectra | |
| SI2313364T1 (sl) | Metode za detekcijo simetričnega dimetilarginina | |
| EG26611A (en) | Methods for measuring the electrical stability of a fluid | |
| EP2348302A4 (en) | APPARATUS FOR DETERMINING THE CONCENTRATION OF A GASEOUS COMPONENT | |
| HK1159252A1 (en) | Measuring system for determining scattering parameters | |
| EP2587265A4 (en) | METHOD FOR DETERMINING OR EVALUATING A SUBSTANCE OF INTEREST | |
| EP2296900A4 (en) | METHOD FOR INK CONDUCTIVITY MEASUREMENT | |
| GB2462730B (en) | Microtome for producing sections of specimens | |
| EP2275814A4 (en) | A-BETA-Oligomer-MEASURING METHOD | |
| EP2786137A4 (en) | METHODS OF MEASURING CONCENTRATIONS OF BIOMOLECULES | |
| EP2232883A4 (en) | SCINTILATION MEASUREMENT METHOD | |
| EP2309223A4 (en) | MEASURING DEVICE | |
| GB2463914B (en) | Sample measurement system | |
| EP2426488A4 (en) | MEASURING METHOD USING INTERNAL REFERENCE SUBSTANCE | |
| EP2351849A4 (en) | REAGENT KIT FOR FRESH MEASUREMENT | |
| HK1172683A1 (en) | Sample measurement system | |
| EP2177611A4 (en) | METHOD FOR MEASURING ANTIGEN CONCENTRATION | |
| GB201012078D0 (en) | Concentration measurement using luminescene | |
| EP2345741A4 (en) | METHOD FOR MEASURING SURVIVIN mRNA | |
| EP2378289A4 (en) | METHOD FOR MEASURING THE SYSTEMIC CONCENTRATION OF A PROTEINED MEDICINAL PRODUCT | |
| DK2430418T3 (da) | Målefremgangsmåde for sensorik |